img

Global Female Contraception Drug Sales Market Report 2024


Published on: 2024-01-04 | No of Pages : 282 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Female Contraception Drug Sales Market Report 2024

The global Female Contraception Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Female Contraception Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
AG-890
Amphora
BAY-1007626
Drospirenone
Others


Segment by Application


Clinic
Hospital
Homecare

The Female Contraception Drug market is analysed and market size information is provided by regions (countries).

Segment by Application

, the Female Contraception Drug market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.




By Company


Addex Therapeutics Ltd
Agile Therapeutics Inc
Bayer AG
Evofem Inc
Hervana Ltd
Mithra Pharmaceuticals SA
Orbis Biosciences Inc
Teva Pharmaceutical Industries Ltd
Viramal Ltd

Table of Content

1 Female Contraception Drug Market Overview
1.1 Female Contraception Drug Product Scope
1.2 Female Contraception Drug Segment by Type
1.2.1 Global Female Contraception Drug Sales by Type (2016 & 2021 & 2027)
1.2.2 AG-890
1.2.3 Amphora
1.2.4 BAY-1007626
1.2.5 Drospirenone
1.2.6 Others
1.3 Female Contraception Drug Segment by Application
1.3.1 Global Female Contraception Drug Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Homecare
1.4 Female Contraception Drug Market Estimates and Forecasts (2016-2027)
1.4.1 Global Female Contraception Drug Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Female Contraception Drug Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Female Contraception Drug Price Trends (2016-2027)

2 Female Contraception Drug Estimates and Forecasts by Region
2.1 Global Female Contraception Drug Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Female Contraception Drug Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Female Contraception Drug Sales Market Share by Region (2016-2021)
2.2.2 Global Female Contraception Drug Revenue Market Share by Region (2016-2021)
2.3 Global Female Contraception Drug Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Female Contraception Drug Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Female Contraception Drug Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Female Contraception Drug Estimates and Projections (2016-2027)
2.4.2 Europe Female Contraception Drug Estimates and Projections (2016-2027)
2.4.3 China Female Contraception Drug Estimates and Projections (2016-2027)
2.4.4 Japan Female Contraception Drug Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Female Contraception Drug Estimates and Projections (2016-2027)
2.4.6 India Female Contraception Drug Estimates and Projections (2016-2027)

3 Global Female Contraception Drug Competition Landscape by Players
3.1 Global Top Female Contraception Drug Players by Sales (2016-2021)
3.2 Global Top Female Contraception Drug Players by Revenue (2016-2021)
3.3 Global Female Contraception Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Female Contraception Drug as of 2020)
3.4 Global Female Contraception Drug Average Price by Company (2016-2021)
3.5 Manufacturers Female Contraception Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Female Contraception Drug Market Size by Type
4.1 Global Female Contraception Drug Historic Market Review by Type (2016-2021)
4.1.1 Global Female Contraception Drug Sales Market Share by Type (2016-2021)
4.1.2 Global Female Contraception Drug Revenue Market Share by Type (2016-2021)
4.1.3 Global Female Contraception Drug Price by Type (2016-2021)
4.2 Global Female Contraception Drug Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Female Contraception Drug Sales Forecast by Type (2022-2027)
4.2.2 Global Female Contraception Drug Revenue Forecast by Type (2022-2027)
4.2.3 Global Female Contraception Drug Price Forecast by Type (2022-2027)

5 Global Female Contraception Drug Market Size by Application
5.1 Global Female Contraception Drug Historic Market Review by Application (2016-2021)
5.1.1 Global Female Contraception Drug Sales Market Share by Application (2016-2021)
5.1.2 Global Female Contraception Drug Revenue Market Share by Application (2016-2021)
5.1.3 Global Female Contraception Drug Price by Application (2016-2021)
5.2 Global Female Contraception Drug Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Female Contraception Drug Sales Forecast by Application (2022-2027)
5.2.2 Global Female Contraception Drug Revenue Forecast by Application (2022-2027)
5.2.3 Global Female Contraception Drug Price Forecast by Application (2022-2027)

6 North America Female Contraception Drug Market Facts & Figures
6.1 North America Female Contraception Drug Sales by Company
6.1.1 North America Female Contraception Drug Sales by Company (2016-2021)
6.1.2 North America Female Contraception Drug Revenue by Company (2016-2021)
6.2 North America Female Contraception Drug Sales Breakdown by Type
6.2.1 North America Female Contraception Drug Sales Breakdown by Type (2016-2021)
6.2.2 North America Female Contraception Drug Sales Breakdown by Type (2022-2027)
6.3 North America Female Contraception Drug Sales Breakdown by Application
6.3.1 North America Female Contraception Drug Sales Breakdown by Application (2016-2021)
6.3.2 North America Female Contraception Drug Sales Breakdown by Application (2022-2027)

7 Europe Female Contraception Drug Market Facts & Figures
7.1 Europe Female Contraception Drug Sales by Company
7.1.1 Europe Female Contraception Drug Sales by Company (2016-2021)
7.1.2 Europe Female Contraception Drug Revenue by Company (2016-2021)
7.2 Europe Female Contraception Drug Sales Breakdown by Type
7.2.1 Europe Female Contraception Drug Sales Breakdown by Type (2016-2021)
7.2.2 Europe Female Contraception Drug Sales Breakdown by Type (2022-2027)
7.3 Europe Female Contraception Drug Sales Breakdown by Application
7.3.1 Europe 122 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 122 Sales Breakdown by Application (2022-2027)

8 China Female Contraception Drug Market Facts & Figures
8.1 China Female Contraception Drug Sales by Company
8.1.1 China Female Contraception Drug Sales by Company (2016-2021)
8.1.2 China Female Contraception Drug Revenue by Company (2016-2021)
8.2 China Female Contraception Drug Sales Breakdown by Type
8.2.1 China Female Contraception Drug Sales Breakdown by Type (2016-2021)
8.2.2 China Female Contraception Drug Sales Breakdown by Type (2022-2027)
8.3 China Female Contraception Drug Sales Breakdown by Application
8.3.1 China 143 Sales Breakdown by Application (2016-2021)
8.3.2 China 143 Sales Breakdown by Application (2022-2027)

9 Japan Female Contraception Drug Market Facts & Figures
9.1 Japan Female Contraception Drug Sales by Company
9.1.1 Japan Female Contraception Drug Sales by Company (2016-2021)
9.1.2 Japan Female Contraception Drug Revenue by Company (2016-2021)
9.2 Japan Female Contraception Drug Sales Breakdown by Type
9.2.1 Japan Female Contraception Drug Sales Breakdown by Type (2016-2021)
9.2.2 Japan Female Contraception Drug Sales Breakdown by Type (2022-2027)
9.3 Japan Female Contraception Drug Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Female Contraception Drug Market Facts & Figures
10.1 Southeast Asia Female Contraception Drug Sales by Company
10.1.1 Southeast Asia Female Contraception Drug Sales by Company (2016-2021)
10.1.2 Southeast Asia Female Contraception Drug Revenue by Company (2016-2021)
10.2 Southeast Asia Female Contraception Drug Sales Breakdown by Type
10.2.1 Southeast Asia Female Contraception Drug Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Female Contraception Drug Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Female Contraception Drug Sales Breakdown by Application
10.3.1 Southeast Asia K Pcs Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Pcs Sales Breakdown by Application (2022-2027)

11 India Female Contraception Drug Market Facts & Figures
11.1 India Female Contraception Drug Sales by Company
11.1.1 India Female Contraception Drug Sales by Company (2016-2021)
11.1.2 India Female Contraception Drug Revenue by Company (2016-2021)
11.2 India Female Contraception Drug Sales Breakdown by Type
11.2.1 India Female Contraception Drug Sales Breakdown by Type (2016-2021)
11.2.2 India Female Contraception Drug Sales Breakdown by Type (2022-2027)
11.3 India Female Contraception Drug Sales Breakdown by Application
11.3.1 India Female Contraception Drug Sales Breakdown by Application (2016-2021)
11.3.2 India Female Contraception Drug Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Female Contraception Drug Business
12.1 Addex Therapeutics Ltd
12.1.1 Addex Therapeutics Ltd Corporation Information
12.1.2 Addex Therapeutics Ltd Business Overview
12.1.3 Addex Therapeutics Ltd Female Contraception Drug Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Addex Therapeutics Ltd Female Contraception Drug Products Offered
12.1.5 Addex Therapeutics Ltd Recent Development
12.2 Agile Therapeutics Inc
12.2.1 Agile Therapeutics Inc Corporation Information
12.2.2 Agile Therapeutics Inc Business Overview
12.2.3 Agile Therapeutics Inc Female Contraception Drug Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Agile Therapeutics Inc Female Contraception Drug Products Offered
12.2.5 Agile Therapeutics Inc Recent Development
12.3 Bayer AG
12.3.1 Bayer AG Corporation Information
12.3.2 Bayer AG Business Overview
12.3.3 Bayer AG Female Contraception Drug Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Bayer AG Female Contraception Drug Products Offered
12.3.5 Bayer AG Recent Development
12.4 Evofem Inc
12.4.1 Evofem Inc Corporation Information
12.4.2 Evofem Inc Business Overview
12.4.3 Evofem Inc Female Contraception Drug Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Evofem Inc Female Contraception Drug Products Offered
12.4.5 Evofem Inc Recent Development
12.5 Hervana Ltd
12.5.1 Hervana Ltd Corporation Information
12.5.2 Hervana Ltd Business Overview
12.5.3 Hervana Ltd Female Contraception Drug Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Hervana Ltd Female Contraception Drug Products Offered
12.5.5 Hervana Ltd Recent Development
12.6 Mithra Pharmaceuticals SA
12.6.1 Mithra Pharmaceuticals SA Corporation Information
12.6.2 Mithra Pharmaceuticals SA Business Overview
12.6.3 Mithra Pharmaceuticals SA Female Contraception Drug Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Mithra Pharmaceuticals SA Female Contraception Drug Products Offered
12.6.5 Mithra Pharmaceuticals SA Recent Development
12.7 Orbis Biosciences Inc
12.7.1 Orbis Biosciences Inc Corporation Information
12.7.2 Orbis Biosciences Inc Business Overview
12.7.3 Orbis Biosciences Inc Female Contraception Drug Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Orbis Biosciences Inc Female Contraception Drug Products Offered
12.7.5 Orbis Biosciences Inc Recent Development
12.8 Teva Pharmaceutical Industries Ltd
12.8.1 Teva Pharmaceutical Industries Ltd Corporation Information
12.8.2 Teva Pharmaceutical Industries Ltd Business Overview
12.8.3 Teva Pharmaceutical Industries Ltd Female Contraception Drug Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Teva Pharmaceutical Industries Ltd Female Contraception Drug Products Offered
12.8.5 Teva Pharmaceutical Industries Ltd Recent Development
12.9 Viramal Ltd
12.9.1 Viramal Ltd Corporation Information
12.9.2 Viramal Ltd Business Overview
12.9.3 Viramal Ltd Female Contraception Drug Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Viramal Ltd Female Contraception Drug Products Offered
12.9.5 Viramal Ltd Recent Development

13 Female Contraception Drug Manufacturing Cost Analysis
13.1 Female Contraception Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Female Contraception Drug
13.4 Female Contraception Drug Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Female Contraception Drug Distributors List
14.3 Female Contraception Drug Customers

15 Market Dynamics
15.1 Female Contraception Drug Market Trends
15.2 Female Contraception Drug Drivers
15.3 Female Contraception Drug Market Challenges
15.4 Female Contraception Drug Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Female Contraception Drug Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Female Contraception Drug Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Female Contraception Drug Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Female Contraception Drug Sales (K Pcs) by Region (2016-2021)
Table 5. Global Female Contraception Drug Sales Market Share by Region (2016-2021)
Table 6. Global Female Contraception Drug Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Female Contraception Drug Revenue Share by Region (2016-2021)
Table 8. Global Female Contraception Drug Sales (K Pcs) Forecast by Region (2022-2027)
Table 9. Global Female Contraception Drug Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Female Contraception Drug Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Female Contraception Drug Revenue Share Forecast by Region (2022-2027)
Table 12. Global Female Contraception Drug Sales (K Pcs) of Key Companies (2016-2021)
Table 13. Global Female Contraception Drug Sales Share by Company (2016-2021)
Table 14. Global Female Contraception Drug Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Female Contraception Drug Revenue Share by Company (2016-2021)
Table 16. Global Female Contraception Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Female Contraception Drug as of 2020)
Table 17. Global Female Contraception Drug Average Price (USD/Pcs) of Key Company (2016-2021)
Table 18. Manufacturers Female Contraception Drug Manufacturing Sites and Area Served
Table 19. Manufacturers Female Contraception Drug Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Female Contraception Drug Sales (K Pcs) by Type (2016-2021)
Table 22. Global Female Contraception Drug Sales Share by Type (2016-2021)
Table 23. Global Female Contraception Drug Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Female Contraception Drug Price (USD/Pcs) by Type (2016-2021)
Table 25. Global Female Contraception Drug Sales Share by Type (2022-2027)
Table 26. Global Female Contraception Drug Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Female Contraception Drug Revenue Share by Type (2022-2027)
Table 28. Global Female Contraception Drug Price (USD/Pcs) by Type (2022-2027)
Table 29. Global Female Contraception Drug Sales (K Pcs) by Application (2016-2021)
Table 30. Global Female Contraception Drug Sales Share by Application (2016-2021)
Table 31. Global Female Contraception Drug Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Female Contraception Drug Price (USD/Pcs) by Application (2016-2021)
Table 33. Global Female Contraception Drug Sales (K Pcs) by Application (2022-2027)
Table 34. Global Female Contraception Drug Sales Share by Application (2022-2027)
Table 35. Global Female Contraception Drug Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Female Contraception Drug Revenue Share by Application (2022-2027)
Table 37. Global Female Contraception Drug Price (USD/Pcs) by Application (2022-2027)
Table 38. North America Female Contraception Drug Sales (K Pcs) by Company (2016-2021)
Table 39. North America Female Contraception Drug Sales Market Share by Company (2016-2021)
Table 40. North America Female Contraception Drug Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Female Contraception Drug Revenue Market Share by Company (2016-2021)
Table 42. North America Female Contraception Drug Sales by Type (2016-2021) & (K Pcs)
Table 43. North America Female Contraception Drug Sales Market Share by Type (2016-2021)
Table 44. North America Female Contraception Drug Sales by Type (2022-2027) & (K Pcs)
Table 45. North America Female Contraception Drug Sales Market Share by Type (2022-2027)
Table 46. North America Female Contraception Drug Sales by Application (2016-2021) & (K Pcs)
Table 47. North America Female Contraception Drug Sales Market Share by Application (2016-2021)
Table 48. North America Female Contraception Drug Sales by Application (2022-2027) & (K Pcs)
Table 49. North America Female Contraception Drug Sales Market Share by Application (2022-2027)
Table 50. Europe Female Contraception Drug Sales (K Pcs) by Company (2016-2021)
Table 51. Europe Female Contraception Drug Sales Market Share by Company (2016-2021)
Table 52. Europe Female Contraception Drug Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Female Contraception Drug Revenue Market Share by Company (2016-2021)
Table 54. Europe Female Contraception Drug Sales by Type (2016-2021) & (K Pcs)
Table 55. Europe Female Contraception Drug Sales Market Share by Type (2016-2021)
Table 56. Europe Female Contraception Drug Sales by Type (2022-2027) & (K Pcs)
Table 57. Europe Female Contraception Drug Sales Market Share by Type (2022-2027)
Table 58. Europe Female Contraception Drug Sales by Application (2016-2021) & (K Pcs)
Table 59. Europe Female Contraception Drug Sales Market Share by Application (2016-2021)
Table 60. Europe Female Contraception Drug Sales by Application (2022-2027) & (K Pcs)
Table 61. Europe Female Contraception Drug Sales Market Share by Application (2022-2027)
Table 62. China Female Contraception Drug Sales (K Pcs) by Company (2016-2021)
Table 63. China Female Contraception Drug Sales Market Share by Company (2016-2021)
Table 64. China Female Contraception Drug Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Female Contraception Drug Revenue Market Share by Company (2016-2021)
Table 66. China Female Contraception Drug Sales by Type (2016-2021) & (K Pcs)
Table 67. China Female Contraception Drug Sales Market Share by Type (2016-2021)
Table 68. China Female Contraception Drug Sales by Type (2022-2027) & (K Pcs)
Table 69. China Female Contraception Drug Sales Market Share by Type (2022-2027)
Table 70. China Female Contraception Drug Sales by Application (2016-2021) & (K Pcs)
Table 71. China Female Contraception Drug Sales Market Share by Application (2016-2021)
Table 72. China Female Contraception Drug Sales by Application (2022-2027) & (K Pcs)
Table 73. China Female Contraception Drug Sales Market Share by Application (2022-2027)
Table 74. Japan Female Contraception Drug Sales (K Pcs) by Company (2016-2021)
Table 75. Japan Female Contraception Drug Sales Market Share by Company (2016-2021)
Table 76. Japan Female Contraception Drug Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Female Contraception Drug Revenue Market Share by Company (2016-2021)
Table 78. Japan Female Contraception Drug Sales by Type (2016-2021) & (K Pcs)
Table 79. Japan Female Contraception Drug Sales Market Share by Type (2016-2021)
Table 80. Japan Female Contraception Drug Sales by Type (2022-2027) & (K Pcs)
Table 81. Japan Female Contraception Drug Sales Market Share by Type (2022-2027)
Table 82. Japan Female Contraception Drug Sales by Application (2016-2021) & (K Pcs)
Table 83. Japan Female Contraception Drug Sales Market Share by Application (2016-2021)
Table 84. Japan Female Contraception Drug Sales by Application (2022-2027) & (K Pcs)
Table 85. Japan Female Contraception Drug Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Female Contraception Drug Sales (K Pcs) by Company (2016-2021)
Table 87. Southeast Asia Female Contraception Drug Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Female Contraception Drug Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Female Contraception Drug Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Female Contraception Drug Sales by Type (2016-2021) & (K Pcs)
Table 91. Southeast Asia Female Contraception Drug Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Female Contraception Drug Sales by Type (2022-2027) & (K Pcs)
Table 93. Southeast Asia Female Contraception Drug Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Female Contraception Drug Sales by Application (2016-2021) & (K Pcs)
Table 95. Southeast Asia Female Contraception Drug Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Female Contraception Drug Sales by Application (2022-2027) & (K Pcs)
Table 97. Southeast Asia Female Contraception Drug Sales Market Share by Application (2022-2027)
Table 98. India Female Contraception Drug Sales (K Pcs) by Company (2016-2021)
Table 99. India Female Contraception Drug Sales Market Share by Company (2016-2021)
Table 100. India Female Contraception Drug Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Female Contraception Drug Revenue Market Share by Company (2016-2021)
Table 102. India Female Contraception Drug Sales by Type (2016-2021) & (K Pcs)
Table 103. India Female Contraception Drug Sales Market Share by Type (2016-2021)
Table 104. India Female Contraception Drug Sales by Type (2022-2027) & (K Pcs)
Table 105. India Female Contraception Drug Sales Market Share by Type (2022-2027)
Table 106. India Female Contraception Drug Sales by Application (2016-2021) & (K Pcs)
Table 107. India Female Contraception Drug Sales Market Share by Application (2016-2021)
Table 108. India Female Contraception Drug Sales by Application (2022-2027) & (K Pcs)
Table 109. India Female Contraception Drug Sales Market Share by Application (2022-2027)
Table 110. Addex Therapeutics Ltd Corporation Information
Table 111. Addex Therapeutics Ltd Description and Business Overview
Table 112. Addex Therapeutics Ltd Female Contraception Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 113. Addex Therapeutics Ltd Female Contraception Drug Product
Table 114. Addex Therapeutics Ltd Recent Development
Table 115. Agile Therapeutics Inc Corporation Information
Table 116. Agile Therapeutics Inc Description and Business Overview
Table 117. Agile Therapeutics Inc Female Contraception Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 118. Agile Therapeutics Inc Female Contraception Drug Product
Table 119. Agile Therapeutics Inc Recent Development
Table 120. Bayer AG Corporation Information
Table 121. Bayer AG Description and Business Overview
Table 122. Bayer AG Female Contraception Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 123. Bayer AG Female Contraception Drug Product
Table 124. Bayer AG Recent Development
Table 125. Evofem Inc Corporation Information
Table 126. Evofem Inc Description and Business Overview
Table 127. Evofem Inc Female Contraception Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 128. Evofem Inc Female Contraception Drug Product
Table 129. Evofem Inc Recent Development
Table 130. Hervana Ltd Corporation Information
Table 131. Hervana Ltd Description and Business Overview
Table 132. Hervana Ltd Female Contraception Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 133. Hervana Ltd Female Contraception Drug Product
Table 134. Hervana Ltd Recent Development
Table 135. Mithra Pharmaceuticals SA Corporation Information
Table 136. Mithra Pharmaceuticals SA Description and Business Overview
Table 137. Mithra Pharmaceuticals SA Female Contraception Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 138. Mithra Pharmaceuticals SA Female Contraception Drug Product
Table 139. Mithra Pharmaceuticals SA Recent Development
Table 140. Orbis Biosciences Inc Corporation Information
Table 141. Orbis Biosciences Inc Description and Business Overview
Table 142. Orbis Biosciences Inc Female Contraception Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 143. Orbis Biosciences Inc Female Contraception Drug Product
Table 144. Orbis Biosciences Inc Recent Development
Table 145. Teva Pharmaceutical Industries Ltd Corporation Information
Table 146. Teva Pharmaceutical Industries Ltd Female Contraception Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 147. Teva Pharmaceutical Industries Ltd Description and Business Overview
Table 148. Teva Pharmaceutical Industries Ltd Female Contraception Drug Product
Table 149. Teva Pharmaceutical Industries Ltd Recent Development
Table 150. Viramal Ltd Corporation Information
Table 151. Viramal Ltd Female Contraception Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 152. Viramal Ltd Description and Business Overview
Table 153. Viramal Ltd Female Contraception Drug Product
Table 154. Viramal Ltd Recent Development
Table 155. Production Base and Market Concentration Rate of Raw Material
Table 156. Key Suppliers of Raw Materials
Table 157. Female Contraception Drug Distributors List
Table 158. Female Contraception Drug Customers List
Table 159. Female Contraception Drug Market Trends
Table 160. Female Contraception Drug Market Drivers
Table 161. Female Contraception Drug Market Challenges
Table 162. Female Contraception Drug Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Female Contraception Drug Product Picture
Figure 2. Global Female Contraception Drug Sales Market Share by Type in 2021 & 2027
Figure 3. AG-890 Product Picture
Figure 4. Amphora Product Picture
Figure 5. BAY-1007626 Product Picture
Figure 6. Drospirenone Product Picture
Figure 7. Others Product Picture
Figure 8. Global Female Contraception Drug Sales Market Share by Application in 2021 & 2027
Figure 9. Clinic Examples
Figure 10. Hospital Examples
Figure 11. Homecare Examples
Figure 12. Global Female Contraception Drug Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Female Contraception Drug Sales Growth Rate (2016-2027) & (US$ Million)
Figure 14. Global Female Contraception Drug Sales (K Pcs) Growth Rate (2016-2027)
Figure 15. Global Female Contraception Drug Price Trends Growth Rate (2016-2027) (USD/Pcs)
Figure 16. Global Female Contraception Drug Revenue Market Share by Region: 2016 VS 2021
Figure 17. Global Female Contraception Drug Revenue Market Share by Region: 2021 VS 2027
Figure 18. North America Female Contraception Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. North America Female Contraception Drug Sales (K Pcs) Growth Rate (2016-2027)
Figure 20. Europe Female Contraception Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. Europe Female Contraception Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 22. China Female Contraception Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. China Female Contraception Drug Sales (Million USD) and Growth Rate (2016-2027)
Figure 24. Japan Female Contraception Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. Japan Female Contraception Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 26. Southeast Asia Female Contraception Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. Southeast Asia Female Contraception Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 28. India Female Contraception Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 29. India Female Contraception Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 30. Global 5 Largest Female Contraception Drug Players Market Share by Revenue in Female Contraception Drug: 2016 & 2020
Figure 31. Female Contraception Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 32. Global Female Contraception Drug Revenue Share by Type (2016-2021)
Figure 33. Global Female Contraception Drug Revenue Growth Rate by Type in 2016 & 2020
Figure 34. Global Female Contraception Drug Revenue Share by Application (2016-2021)
Figure 35. Global Female Contraception Drug Revenue Growth Rate by Application in 2016 & 2020
Figure 36. North America Female Contraception Drug Sales Market Share by Type in 2020
Figure 37. North America Female Contraception Drug Sales Market Share by Application in 2020
Figure 38. Europe Female Contraception Drug Sales Market Share by Type in 2020
Figure 39. Europe Female Contraception Drug Sales Market Share by Application in 2020
Figure 40. China Female Contraception Drug Sales Market Share by Type in 2020
Figure 41. China Female Contraception Drug Sales Market Share by Application in 2020
Figure 42. Japan Female Contraception Drug Sales Market Share by Type in 2020
Figure 43. Japan Female Contraception Drug Sales Market Share by Application in 2020
Figure 44. Southeast Asia Female Contraception Drug Sales Market Share by Type in 2020
Figure 45. Southeast Asia Female Contraception Drug Sales Market Share by Application in 2020
Figure 46. India Female Contraception Drug Sales Market Share by Type in 2020
Figure 47. India Female Contraception Drug Sales Market Share by Application in 2020
Figure 48. Key Raw Materials Price Trend
Figure 49. Manufacturing Cost Structure of Female Contraception Drug
Figure 50. Manufacturing Process Analysis of Female Contraception Drug
Figure 51. Female Contraception Drug Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed